Tag: chronic ischaemic cardiovascular disease
BioVentrix receives FDA expanded access program approval for ischemic heart failure treatment system
BioVentrix, a privately held medical device company focused on the development of less invasive ther...
Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months
Nearly a quarter of patients with chronic ischaemic cardiovascular disease are dead o...